Human gut microbes impact host serum metabolome and insulin sensitivity

Nature

Volumn 535, Issue 7612, 2016, Pages 376-381

  Pedersen, Helle Krogh ^a   Gudmundsdottir, Valborg ^a   Nielsen, Henrik Bjørn ^a   Hyotylainen, Tuulia ^b,c,d   Nielsen, Trine ^e   Jensen, Benjamin A H ^f   Forslund, Kristoffer ^g   Hildebrand, Falk ^g,h,i   Prifti, Edi ^j,k   Falony, Gwen ^i,l   Le Chatelier, Emmanuelle ^j   Levenez, Florence ^j   Doré, Joel ^j   Mattila, Ismo ^d,m   Plichta, Damian R ^a   Pöhö, Päivi ^d,n   Hellgren, Lars I ^a   Arumugam, Manimozhiyan ^e   Sunagawa, Shinichi ^g,o   Vieira Silva, Sara ^i,l   Jørgensen, Torben ^p,q   Holm, Jacob Bak ^f   Trošt, Kajetan ^m   Kristiansen, Karsten ^f,r   Brix, Susanne ^a   Raes, Jeroen ^h,i,l   Wang, Jun ^f,r,s,t,u   Hansen, Torben ^e,v   Bork, Peer ^g,w,x   Brunak, Søren ^a,y   Oresic, Matej ^c,d,m   Ehrlich, S Dusko ^j,z   Pedersen, Oluf ^e,p   more..

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b ÖREBRO UNIVERSITY   (Sweden)

^c UNIVERSITY OF TURKU   (Finland)

^d VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^e Capital Region   (Denmark)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^h VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

ⁱ DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^j UNIVERSITÉ PARIS SACLAY   (France)

^k Institute of Cardiometabolism and Nutrition (ICAN)   (France)

^l REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^m STENO DIABETES CENTER   (Denmark)

ⁿ UNIVERSITY OF HELSINKI   (Finland)

^o ETH ZURICH   (Switzerland)

^p UNIVERSITY OF COPENHAGEN   (Denmark)

^q GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^r BGI SHENZHEN   (China)

^s KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^t MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

^u UNIVERSITY OF HONG KONG   (Hong Kong)

^v UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^w MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^x UNIVERSITY OF WÜRZBURG   (Germany)

^y University of Copenhagen   (Denmark)

^z GUY S HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRANCHED CHAIN AMINO ACID; INSULIN;

CARDIOVASCULAR DISEASE; DIGESTIVE SYSTEM; METABOLISM; MICROBIAL ACTIVITY; MICROBIAL COMMUNITY; RODENT; SERUM;

ARTICLE; BACTERIUM IDENTIFICATION; BACTEROIDES VULGATUS; BIOSYNTHESIS; CARDIOVASCULAR DISEASE; GENE FUNCTION; GENE MAPPING; GENETIC CODE; GLUCOSE INTOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE FLORA; METABOLIC DISORDER; METAGENOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; PREVOTELLA; PREVOTELLA COPRI; PRIORITY JOURNAL; ANIMAL; BACTEROIDES; BLOOD; C57BL MOUSE; DIET RESTRICTION; MALE; METABOLISM; METABOLOME; METAGENOME; MICROBIOLOGY; MOUSE; NETHERLANDS; PHYSIOLOGY; SERUM;

DENMARK;

BACTERIA (MICROORGANISMS); BACTEROIDES VULGATUS; MUS; PREVOTELLA;

AMINO ACIDS, BRANCHED-CHAIN; ANIMALS; BACTEROIDES; CARDIOVASCULAR DISEASES; FASTING; GASTROINTESTINAL MICROBIOME; GLUCOSE INTOLERANCE; HUMANS; INSULIN RESISTANCE; MALE; METABOLOME; METAGENOME; MICE; MICE, INBRED C57BL; NETHERLANDS; PREVOTELLA; SERUM;

EID: 84978081339     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature18646     Document Type: Article

References (45)

1. Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541-546 (2013).
2. Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60 (2012).
3. Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99-103 (2013).
4. Forslund, K. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262-266 (2015).
5. Vrieze, A. et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913-916 (2012).
6. Ridaura, V. K. et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341, 1241214 (2013).
7. Holmes, E., Li, J. V., Marchesi, J. R. & Nicholson, J. K. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab. 16, 559-564 (2012).
8. Wang, T. J. et al. Metabolite profiles and the risk of developing diabetes. Nat. Med. 17, 448-453 (2011).
9. Lee, C. C. et al. Branched-chain amino acids and insulin metabolism: The Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 39, 582-588 (2016).
10. Rhee, E. P. et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J. Clin. Invest. 121, 1402-1411 (2011).
11. Kotronen, A. et al. Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. Diabetologia 52, 684-690 (2009).
12. Floegel, A. et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62, 639-648 (2013).
13. Roberts, L. D., Koulman, A. & Griffin, J. L. Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome. Lancet Diabetes Endocrinol. 2, 65-75 (2014).
14. Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419 (1985).
15. Alberti, K. G. M. M., Zimmet, P. & Shaw, J. Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet. Med. 23, 469-480 (2006).
16. Aura, A. M. Microbial metabolism of dietary phenolic compounds in the colon. Phytochem. Rev. 7, 407-429 (2008).
17. Velagapudi, V. R. et al. The gut microbiota modulates host energy and lipid metabolism in mice. J. Lipid Res. 51, 1101-1112 (2010).
18. Tso, S. C. et al. Structure-based design and mechanisms of allosteric inhibitors for mitochondrial branched-chain α -ketoacid dehydrogenase kinase. Proc. Natl Acad. Sci. USA 110, 9728-9733 (2013).
19. Forouhi, N. G. et al. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol. 2, 810-818 (2014).
20. Roberts, L. D., Virtue, S., Vidal-Puig, A., Nicholls, A. W. & Griffin, J. L. Metabolic phenotyping of a model of adipocyte differentiation. Physiol. Genomics 39, 109-119 (2009).
21. Collins, J. M. et al. De novo lipogenesis in the differentiating human adipocyte can provide all fatty acids necessary for maturation. J. Lipid Res. 52, 1683-1692 (2011).
22. Summers, S. A. Ceramides in insulin resistance and lipotoxicity. Prog. Lipid Res. 45, 42-72 (2006).
23. Raichur, S. et al. CerS2 haploinsufficiency inhibits β -oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Cell Metab. 20, 687-695 (2014).
24. Turpin, S. M. et al. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab. 20, 678-686 (2014).
25. Kanehisa, M. et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res. 36, D480-D484 (2008).
26. Watson, E. et al. Interspecies systems biology uncovers metabolites affecting C. elegans gene expression and life history traits. Cell 156, 759-770 (2014).
27. Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222-227 (2012).
28. Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174-180 (2011).
29. Scher, J. U. et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife 2, e01202 (2013).
30. Dewulf, E. M. et al. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62, 1112-1121 (2013).
31. Newgard, C. B. et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9, 311-326 (2009).
32. Charon, N. W., Johnson, R. C. & Peterson, D. Amino acid biosynthesis in the spirochete Leptospira: evidence for a novel pathway of isoleucine biosynthesis. J. Bacteriol. 117, 203-211 (1974).
33. Umbarger, H. E. Amino acid biosynthesis and its regulation. Annu. Rev. Biochem. 47, 532-606 (1978).
34. Shin, S.-Y. et al. An atlas of genetic influences on human blood metabolites. Nat. Genet. 46, 543-550 (2014).
35. Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-757 (2011).
36. Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179-185 (2012).
37. Heimesaat, M. M. et al. Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J. Immunol. 177, 8785-8795 (2006).
38. Dillon, S. M. et al. Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection. Mucosal Immunol. 9, 24-37 (2016).
39. Kovatcheva-Datchary, P. et al. Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella. Cell Metab. 22, 971-982 (2015).
40. Laferrère, B. et al. Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci. Transl. Med. 3, 80re2 (2011).
41. Lynch, C. J. & Adams, S. H. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat. Rev. Endocrinol. 10, 723-736 (2014).
42. Jang, C. et al. A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nat. Med. 22, 421-426 (2016).
43. Herman, M. A., She, P., Peroni, O. D., Lynch, C. J. & Kahn, B. B. Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. J. Biol. Chem. 285, 11348-11356 (2010).
44. Pietiläinen, K. H. et al. Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med. 5, e51 (2008).
45. Shin, A. C. et al. Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism. Cell Metab. 20, 898-909 (2014).